IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

OUP Management Co., LLC

Portfolio Profile

CIK: 0001880124 | Bala Cynwyd, PA

$44.5M
AUM
12
Positions
99.57%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Centessa Pharmaceuticals plc(CNTA)2,937,615$19.0M42.74%
2Aerovate Therapeutics Inc.603,762$8.2M18.43%
3Cyteir Therapeutics, Inc.2,459,572$7.0M15.71%
4PMV Pharmaceuticals, Inc.(PMVP)989,232$6.1M13.66%
5Graphite Bio(GRPH)406,308$1.0M2.27%
6Selecta Biosciences, Inc.(SELBUSD)862,543$914.3K2.06%
7Vor Biopharma Inc.374,714$794.4K1.79%
8eFFECTOR Therapeutics, Inc.1,025,697$615.3K1.38%
9Precision BioSciences, Inc.1,123,913$383.6K0.86%
10Spero Therapeutics, Inc.(SPRO)249,070$301.4K0.68%

Sector Allocation

Latest filing, equity positions only

Healthcare57.08% · $25.4M
Unclassified42.92% · $19.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare42.19%57.08%+14.89%
Unclassified57.81%42.92%-14.89%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$221.9K | 16 pos.
$131.3K | 16 pos.
$72.7K | 15 pos.
$64.2K | 15 pos.
$61.3M | 14 pos.
$50.1M | 14 pos.
Cap SizePrev %Curr %Change
Unclassified57.81%42.92%-14.89%
Mid Cap31.01%42.74%+11.73%
Micro Cap11.18%14.34%+3.16%
$58.6M | 12 pos.
$44.5M | 12 pos.
Q4
21
Q1
22
Q2
22
Q3
22
Q4
22
Q1
23
Q2
23
Q3
23

Recent Activity

Quarter-over-quarter position changes

1
New
1
Closed
0
Increased
0
Decreased
11
Unchanged